Schizoaffective disorder and metabolic syndrome: A meta-analytic comparison with schizophrenia and other non-affective psychoses.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Psychiatric Research

• Publication date

  2015-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jpsychires.2015.04.028PMID 26004300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Data analysis 2

  2016cited by this paper
• National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

  2015cited by this paper
• Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis.

  2015cited by this paper
• Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis

  2014influential reference
• The metabolic syndrome and risk of coronary artery disease in patients with chronic schizophrenia or schizoaffective disorder in a chronic mental institute

  2014influential reference
• Increased cardiovascular risk in patients with severe mental illness

  2014influential reference
• Physical activity interventions for people with mental illness: a systematic review and meta-analysis.

  2014cited by this paper
• Health-related quality of life and metabolic risk in patients with psychosis.

  2014cited by this paper
• Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study.

  2014influential reference
• The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis

  2014cited by this paper
• Cardiovascular risk factors among people with severe mental illness in Italy: a cross-sectional comparative study.

  2014cited by this paper
• Psychotic disorder is an independent risk factor for increased fasting glucose and waist circumference

  2014cited by this paper
• Endothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia

  2014influential reference
• A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice

  2013influential reference
• A meta-analysis of cardio-metabolic abnormalities in drug naive, first-epidode and multi-episode patients with schizophrenia versus general population controls, Russian version

  2013cited by this paper
• Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses.

  2013influential reference
• Bipolar disorder, schizophrenia, and metabolic syndrome.

  2013cited by this paper
• Bipolar Disorder, Schizophrenia, and Metabolic Syndrome

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Metabolic Syndrome in People Suffering from Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis

  2013cited by this paper
• Antidepressant use and new‐onset diabetes: a systematic review and meta‐analysis

  2013cited by this paper
• Racial patterns of cardiovascular disease risk factors in serious mental illness and the overall U.S. population.

  2013influential reference
• A meta‐analysis of cardio‐metabolic abnormalities in drug naïve, first‐episode and multi‐episode patients with schizophrenia versus general population controls

  2013cited by this paper
• Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.

  2013influential reference
• Metabolic syndrome and health-related quality of life in patients with schizophrenia.

  2013influential reference
• Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis

  2012influential reference
• The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.

  2012influential reference
• Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study

  2012cited by this paper
• Metabolic syndrome and type 2 diabetes in chronic institutionalized patients with schizophrenia

  2012influential reference
• Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics

  2012influential reference
• Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.

  2012cited by this paper
• Lithium toxicity profile: a systematic review and meta-analysis.

  2012cited by this paper
• Measurement of waist circumference at different sites affects the detection of abdominal obesity and metabolic syndrome among psychiatric patients.

  2012influential reference
• Psychobiology and psychosocial functioning of schizoaffective disorder.

  2011cited by this paper
• Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

  2011cited by this paper
• Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness

  2011influential reference
• Do they Actually Work Across Borders? Evaluation of two Measures of Psychological Distress as Screening Instruments in a Non Anglo-Saxon Country

  2011cited by this paper
• Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross‐sectional study

  2011influential reference
• Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications

  2011cited by this paper
• Prevalence of metabolic syndrome in patients with schizophrenia

  2011influential reference
• Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia

  2011influential reference
• Schizoaffective Disorder

  2011cited by this paper
• Erratum to: Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies

  2010cited by this paper
• A randomized controlled trial of the effect of a pharmaceutical care program on improving adherence to statin therapy: The statin intervention research project (STIPT)

  2010influential reference
• Antidepressants and body weight: a comprehensive review and meta-analysis.

  2010cited by this paper
• Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects

  2010cited by this paper
• Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies

  2010cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

  2010cited by this paper
• Sindrome metabolica, disturbi dello spettro schizofrenico e trattamenti. Risultati di uno studio naturalistico

  2010influential reference
• Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients.

  2010cited by this paper
• The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

  2010cited by this paper
• The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness

  2010influential reference
• Prevalence of metabolic syndrome in patients with psychotic disorders in the Netherlands.

  2009influential reference
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

  2009influential reference
• Metabolic syndrome in people with schizophrenia: a review

  2009cited by this paper
• Prevalence of metabolic syndrome among Australians with severe mental illness

  2009influential reference
• Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data

  2009cited by this paper
• [The prevalence of metabolic syndrome and related factors in patients with schizophrenia].

  2008influential reference
• Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: Systematic review and metaanalysis

  2008cited by this paper
• Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature

  2008influential reference
• The HPA axis in major depression: classical theories and new developments.

  2008cited by this paper
• Metabolic Syndrome Pandemic

  2008cited by this paper
• Risk Factors of Metabolic Syndrome among Egyptian Patients with Schizophrenia

  2008influential reference
• A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study.

  2008influential reference
• Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program.

  2008cited by this paper
• Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005.

  2008cited by this paper
• Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies.

  2007cited by this paper
• Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder.

  2007cited by this paper
• Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia.

  2007cited by this paper
• Obesity and Metabolic Syndrome in a Psychiatric Rehabilitation Service

  2007cited by this paper
• Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community.

  2007influential reference
• Risk for coronary heart disease in people with severe mental illness

  2006cited by this paper
• Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population.

  2006cited by this paper
• Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.

  2006cited by this paper
• Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

  2006cited by this paper
• The metabolic syndrome--a new worldwide definition.

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005influential reference
• Characterizing Coronary Heart Disease Risk in Chronic Schizophrenia: High Prevalence of the Metabolic Syndrome

  2004cited by this paper
• The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype.

  2004cited by this paper
• Consensus Statement

  2004cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

  2002influential reference
• Reliability and Validity

  2001cited by this paper
• Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis.

  2000cited by this paper
• Methods for Meta-Analysis in Medical Research

  2000cited by this paper
• Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data.

  2000cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Banting lecture 1988

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Cardiovascular Disease

  1995cited by this paper
• Role of insulin resistance in human disease (syndrome X): an expanded definition.

  1993cited by this paper
• Metabolic disease.

  1992cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• ANOFFICIAL JOURNAL oftheAMERICAN HEARTASSOCIATION

  1972cited by this paper
• journal homepage: www.elsevier.com/locate/schres

  year unknowninfluential reference

• The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis.

  2025cites this paper
• Unraveling the prevalence and key influencers of metabolic syndrome in Drug-Naïve, first-episode major depressive disorder patients with psychotic symptoms: A decision tree modeling approach.

  2025cites this paper
• Metabolic syndrome in psychiatric disorders

  2024cites this paper
• Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review

  2024cites this paper
• General medical comorbidities in psychotic disorders in the Finnish SUPER study

  2024cites this paper
• Rethinking Palliative Care in Psychiatry.

  2023cites this paper
• Twelve-month outcomes in overweight/obese users with mental disorders following a multi-element treatment including diet, physical activity, and positive thinking: The real-world “An Apple a Day” controlled trial

  2022cites this paper
• Physical illness comorbidity and its influencing factors among persons with severe mental illness in Rural China.

  2022cites this paper
• Use of Psychoeducation for Psychotic Disorder Patients Treated With Modern, Long-Acting, Injected Antipsychotics

  2021cites this paper
• Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study

  2020cites this paper
• Cardiovascular Manifestations in Schizophrenia

  2020cites this paper
• Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966

  2020cites this paper
• Metabolic syndrome in the population of psychiatric patients in Novi Sad

  2020cites this paper
• Trauma, PTSD and post-traumatic stress spectrum: 15 years’ experience on a multidimensional approach to trauma related psychopathology

  2020cites this paper
• Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics.

  2020cites this paper
• Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy.

  2019cites this paper
• Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics

  2019cites this paper
• Epigenetic clock analysis of blood samples from Japanese schizophrenia patients

  2019cites this paper
• Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis.

  2019cites this paper
• A novel biomarker of cardiometabolic pathology in schizophrenia?

  2019cites this paper
• The Prevalence Of Metabolic Disorders And Their Associated Risk Factors In Forensic Patients With Schizophrenia Spectrum Disorders On Clozapine Compared To Haloperidol At Valkenberg Hospital

  2019cites this paper
• Acute Bouts of Exercising Improved Mood, Rumination and Social Interaction in Inpatients With Mental Disorders

  2018cites this paper
• Comparison of the prevalence of metabolic syndrome in patients with schizophrenia and bipolar disorder: a cross-sectional study from Black Sea region

  2018cites this paper
• Reducing the Mortality Gap in People With Severe Mental Disorders: The Role of Lifestyle Psychosocial Interventions

  2018cites this paper
• Association Between First Episode Schizophrenia, Metabolic Syndrome and Insulin Resistance-Related Proteins in Female Balb/C Mice

  2018cites this paper
• Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications

  2018cites this paper
• Longer telomeres in elderly schizophrenia are associated with long-term hospitalization in the Japanese population.

  2018cites this paper
• Cardiovascular disease in patients with schizophrenia

  2017cites this paper
• Metabolic syndrome or glucose challenge in first episode of psychosis?

  2017cites this paper
• Schizophrenie und somatische Komorbiditäten

  2017cites this paper
• Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: A cross-sectional study.

  2017cites this paper
• Paliperidone for the treatment of schizoaffective disorder

  2016cites this paper
• ROMANIAN JOURNAL OF PSYCHOPHARMACOLOGY

  2016influential citation
• Employment and occupation effects on late-life depressive symptoms among older Koreans: a cross-sectional population survey

  2016cites this paper
• The association between PTSD and metabolic syndrome: A role for comorbid depression?

  2015cites this paper
• Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis.

  2015cites this paper
• METABOLIC SYNDROME IN THE POPULATION OF PSYCHIATRIC PATIENTS IN NOVI SAD UNIVERSITY OF NOVI SAD, MEDICAL FACULTY HAJDUK VELJKOVA 3; CLINICAL CENTRE OF VOJVODINA, CLINIC FOR PSYCHIATRY

  year unknowncites this paper